Model-informed Drug Development Intensive Interactive Courses

Predicting and evaluating complex DDIs—application of the Simcyp Population-based Simulator to real-life cases. August 3-4, 2026 |  Tokyo, Japan VENUE: TBC LAPTOP: Delegates are required to bring a laptop computer, and will be provided with access to the Simcyp Simulator via Amazon Workspaces for the duration of the course.  COURSE MATERIAL: will be provided electronically via LearnUpon. No printed materials will be given out during the course. Read more

 August 5-6, 2026 | IN PERSON (Tokyo, Japan) Overview: This hands-on workshop is designed to deepen your understanding of the biopharmaceutic aspects of physiologically based pharmacokinetic (PBPK) modelling and its practical applications, including formulation development, virtual bioequivalence and automated safe space assessment. Covering both foundational concepts and case studies. This event offers a comprehensive learning experience for professionals in industry, academia, and regulatory agencies. Workshop Highlights: 1. Overview of the biopharmaceutic/oral absorption modelling tools including modelling of in vitro solubility and dissolution experiments to better understand your data and parameterise biopharmaceutic aspects of PBPK models. 2. Handling of different formulations ranging from suspensions and IR to controlled and modified release including ASDs and salts. 3. Mechanistic modelling of food effects including advanced aspects such as the Magenstrasse. 4. Application of virtual bioequivalence (VBE) and automated safe space tools. 5. Learning best practices and regulatory requirements through case studies. Read more

October 5-9, 2026 | ONLINE From Discovery to First-in-human (FIH) Using IVIVE-PBPK Modeling In this focused workshop you will use the dynamic models within the Simcyp Discovery Simulator to prioritise compounds for progress to the next stage of development using information available in early drug discovery. You will use information on clearance, absorption, tissue distribution and DDI liability to inform compound selection. Finally, from the originally large database, only a few compounds will be selected for FIH and the simulation results compared with available clinical data. The case studies will cover various elements of model development including absorption, distribution and elimination. Optimal in vitro and clinical data sets will be discussed. Participants will learn how to choose the most suitable models and also investigate the impact of various relevant assumptions on model performance. Requirements for regulatory submissions will also be discussed. It is assumed that the participants have some familiarity with the fundamentals of PBPK modeling and have hands-on experience. Live Online Courses There are no refunds for Live Online courses.  Certara retains the right to cancel the course 30 calendar days before the first session, in which case participants will receive a full refund. Read more

October 5-9, 2026 | ONLINE Predicting and evaluating complex DDIs—application of the Simcyp Population-based Simulator to real-life cases. Live Online Courses There are no refunds for Live Online courses.  Certara retains the right to cancel the course 30 calendar days before the first session, in which case participants will receive a full refund. Read more

Certara UK Limited is running a Simcyp hands-on workshop discussing the changes to pharmacokinetics during pregnancy and the prediction of pharmacokinetics (including in the milk) during lactation. Population based Physiologically Based Pharmacokinetic (PBPK) approach will be utilized to describe the pharmacokinetics during pregnancy and lactation and to determine population variability. The major topics covered are: Maternal and fetal gestational age-dependent physiological changes Prediction of maternal and fetal drug pharmacokinetics Ways of incorporating ex vivo experimental data on transplacental kinetics within the PBPK model Handling gestational age-varying covariates during simulation Prediction of PK in breastfeeding mothers and milk exposure using lactation models Prediction of infant dose for breastfed infant This course will be run using the Amazon Workspaces in Cloud; please ensure you have access to a computer. Live Online Courses There are no refunds for Live Online courses.  Certara retains the right to cancel the course 30 calendar days before the first session, in which case participants will receive a full refund. Read more

October 19-30, 2026 | ONLINE Live sessions typically run for 3hrs per day via Teams with assignments to complete out of session. Incorporating population variability into mechanistic prediction of PK and modeling PK/PD The model-informed approach to various aspects of drug development is rapidly being adopted by the leading pharmaceutical companies. The Simcyp workshops focus on the optimal use of compound-specific in vitro and in vivo data together with system specific information related to humans to simulate and understand drug behavior in various target populations. This integrated approach informs decisions related to Investigational New Drugs and assists with the conduct and optimal design of clinical studies. The ultimate aim is to better understand drug PK/PD properties, reduce the cost and time of drug development, improve the quality of regulatory submissions, and eventually implement precision medicine. Live Online Courses There are no refunds for Live Online courses.  Certara retains the right to cancel the course 30 calendar days before the first session, in which case participants will receive a full refund. Read more